Latest: Merck to buy Seagen fails to agree on price
ADC评论
August 27, 2022
According to Bloomberg, citing people familiar with the matter, the two companies have so far failed to agree on a price in talks to acquire
Category: News
EU approves Roctavian for severe hemophilia A
ADC评论
August 26, 2022
On August 24, BioMarin announced that the European Union approved the conditional marketing of Roctavian (Valoctocogene roxaparvovec) gene therapy for the treatment of adults with
Paxlovid doesn’t help young people
ADC评论
August 26, 2022
On August 24, the “New England Journal of Medicine” published a real-world data of Pfizer’s new crown oral drug Paxlovid (nirmatrelvir + ritonavir) against Omicron
Merck: FDA has granted MK-2060 Fast Track designation
ADC评论
August 25, 2022
On August 23, Merck announced that the FDA has granted Fast Track designation to its intravenous anticoagulant drug MK-2060 for reducing the risk of major
Daiichi Sankyo: Quizartinib launched in Europe to treat AML
ADC评论
August 25, 2022
On August 23, Daiichi Sankyo announced that the European Medicines Agency (EMA) has completed the marketing authorization validation of Quizartinib for the treatment of adults
Pfizer and BioNTech Submit Emergency Use Authorization Application to FDA for Omicron Bivalent Vaccine
ADC评论
August 24, 2022
NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S.
FDA approves first antagonist for adult major depressive disorder
ADC评论
August 20, 2022
On August 19, Axsome Therapeutics announced that the US FDA approved Auvelity (dextromethorphan 45mg + bupropion 105mg) compound sustained-release tablets for the treatment of adult
Atomwise partners with Sanofi to develop five targeted drugs
ADC评论
August 19, 2022
On August 17, Atomwise announced that it has entered into a strategic and exclusive research collaboration with Sanofi to leverage its AtomNet® platform for computational
UK approves first Omicron bivalent vaccine
ADC评论
August 18, 2022
On August 15, the UK Medicines and Health Products Administration (MHRA) approved the bivalent vaccine mRNA-1273.214 produced by Moderna against both the Omicron variant BA.1
Sanofi’s amcenestrant clinical failure will halt development
ADC评论
August 18, 2022
PARIS, August 17, 2022. Sanofi is discontinuing the global clinical development program of amcenestrant, an investigational oral selective estrogen receptor degrader (SERD). The decision is
FDA accepts Polivy in combination with R-CHP for DLBCL
ADC评论
August 17, 2022
FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma The Food and Drug Administration (FDA)
The first human-to-dog transmission of monkeypox
ADC评论
August 16, 2022
According to the British “Daily Telegraph” on the 14th, a domestic pet dog in Paris, France, was infected with the monkeypox virus after sleeping in
